DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice

BMC Immunology

Volumn 12, Issue , 2011, Pages

  Werner, Jens M ^a   Busl, Elisabeth ^a   Farkas, Stefan A ^a   Schlitt, Hans J ^a   Geissler, Edward K ^a   Hornung, Matthias ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CELL MARKER; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; L SELECTIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; KLRB1C PROTEIN, MOUSE; LY ANTIGEN; MEMBRANE ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; IMMUNOREGULATION; LIVER; LIVER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SPLEEN; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER T CELL; SECRETION;

ANIMALS; ANTIGENS, LY; ANTIGENS, SURFACE; CYTOKINES; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; PHENOTYPE; SPLEEN;

EID: 79955444328     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-12-26     Document Type: Article

References (47)

1. Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol 11:197-206.
2. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name?. Nat Rev Immunol 2004, 4:231-7. 10.1038/nri1309, 15039760.
3. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000, 21:573-83. 10.1016/S0167-5699(00)01735-7, 11094262.
4. Lantz O, Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 1994, 180:1097-106. 10.1084/jem.180.3.1097, 2191643, 7520467.
5. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004, 22:817-90. 10.1146/annurev.immunol.22.012703.104608, 15032598.
6. Burdin N, Brossay L, Degano M, Iijima H, Gui M, Wilson IA, Kronenberg M. Structural requirements for antigen presentation by mouse CD1. Proc Natl Acad Sci USA 2000, 97:10156-61. 27774, 10963678.
7. Burdin N, Kronenberg M. CD1-mediated immune responses to glycolipids. Curr Opin Immunol 1999, 11:326-31. 10.1016/S0952-7915(99)80052-1, 10375559.
8. Joyce S, Woods AS, Yewdell JW, Bennink JR, De Silva AD, Boesteanu A, Balk SP, Cotter RJ, Brutkiewicz RR. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 1998, 279:1541-4. 10.1126/science.279.5356.1541, 9488653.
9. Kawano T, Tanaka Y, Shimizu E, Kaneko Y, Kamata N, Sato H, Osada H, Sekiya S, Nakayama T, Taniguchi M. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. Int Immunol 1999, 11:881-7. 10.1093/intimm/11.6.881, 10360961.
10. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 2000, 191:1895-903. 2213523, 10839805.
11. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, Taniguchi M. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997, 278:1623-6. 10.1126/science.278.5343.1623, 9374462.
12. Arase H, Saito T, Phillips JH, Lanier LL. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol 2001, 167:1141-4.
13. Moodycliffe AM, Maiti S, Ullrich SE. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation. J Immunol 1999, 162:5156-63.
14. Ortaldo JR, Winkler-Pickett R, Mason AT, Mason LH. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells. J Immunol 1998, 160:1158-65.
15. Gonzalez A, Andre-Schmutz I, Carnaud C, Mathis D, Benoist C. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes. Nat Immunol 2001, 2:1117-25. 10.1038/ni738, 11713466.
16. Adachi K, Tsutsui H, Seki E, Nakano H, Takeda K, Okumura K, Van Kaer L, Nakanishi K. Contribution of CD1d-unrestricted hepatic DX5+ NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice. Int Immunol 2004, 16:787-98. 10.1093/intimm/dxh080, 15096477.
17. Hornung M, Farkas SA, Sattler C, Schlitt HJ, Geissler EK. DX5+ NKT cells induce the death of colitis-associated cells: involvement of programmed death ligand-1. Eur J Immunol 2006, 36:1210-21. 10.1002/eji.200535332, 16619286.
18. Charbonnier LM, van Duivenvoorde LM, Apparailly F, Cantos C, Han WG, Noel D, Duperray C, Huizinga TW, Toes RE, Jorgensen C, et al. Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells. J Immunol 2006, 177:3806-13.
19. Osada T, Nagawa H, Shibata Y. Tumor-infiltrating effector cells of alpha-galactosylceramide-induced antitumor immunity in metastatic liver tumor. J Immune Based Ther Vaccines 2004, 2:7. 10.1186/1476-8518-2-7, 479697, 15251043.
20. Lan F, Zeng D, Higuchi M, Higgins JP, Strober S. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol Blood Marrow Transplant 2003, 9:355-63. 10.1016/S1083-8791(03)00108-3, 12813443.
21. Margalit M, Ilan Y, Ohana M, Safadi R, Alper R, Sherman Y, Doviner V, Rabbani E, Engelhardt D, Nagler A. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes. Bone Marrow Transplant 2005, 35:191-7. 10.1038/sj.bmt.1704719, 15558045.
22. Pellicci DG, Hammond KJ, Coquet J, Kyparissoudis K, Brooks AG, Kedzierska K, Keating R, Turner S, Berzins S, Smyth MJ, et al. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. J Immunol 2005, 175:4416-25.
23. Wingender G, Kronenberg M. Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation. Am J Physiol Gastrointest Liver Physiol 2008, 294:G1-8.
24. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002, 2:557-68.
25. Yang Y, Ueno A, Bao M, Wang Z, Im JS, Porcelli S, Yoon JW. Control of NKT cell differentiation by tissue-specific microenvironments. J Immunol 2003, 171:5913-20.
26. Kim CH, Johnston B, Butcher EC. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 2002, 100:11-6. 10.1182/blood-2001-12-0196, 12070001.
27. Chen H, Huang H, Paul WE. NK1.1+ CD4+ T cells lose NK1.1 expression upon in vitro activation. J Immunol 1997, 158:5112-9.
28. Schumann J, Voyle RB, Wei BY, MacDonald HR. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells. J Immunol 2003, 170:5815-9.
29. Chun T, Page MJ, Gapin L, Matsuda JL, Xu H, Nguyen H, Kang HS, Stanic AK, Joyce S, Koltun WA, et al. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J Exp Med 2003, 197:907-18. 10.1084/jem.20021366, 2193895, 12682110.
30. Eberl G, MacDonald HR. Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 1998, 9:345-53. 10.1016/S1074-7613(00)80617-2, 9768754.
31. Wilson MT, Johansson C, Olivares-Villagomez D, Singh AK, Stanic AK, Wang CR, Joyce S, Wick MJ, Van Kaer L. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci USA 2003, 100:10913-8. 10.1073/pnas.1833166100, 196902, 12960397.
32. Harada M, Seino K, Wakao H, Sakata S, Ishizuka Y, Ito T, Kojo S, Nakayama T, Taniguchi M. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Int Immunol 2004, 16:241-7. 10.1093/intimm/dxh023, 14734609.
33. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 2009, 229:152-72. 10.1111/j.1600-065X.2009.00782.x, 19426221.
34. Hornung M, Lindemann D, Kraus C, Peters A, Berberich I. The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IGM-induced growth arrest. Eur J Immunol 1998, 28:3812-23. 10.1002/(SICI)1521-4141(199811)28:11<3812::AID-IMMU3812>3.0.CO;2-N, 9842924.
35. Falschlehner C, Ganten TM, Koschny R, Schaefer U, Walczak H. TRAIL and Other TRAIL Receptor Agonists as Novel Cancer Therapeutics. Adv Exp Med Biol 2009, 647:195-206. 10.1007/978-0-387-89520-8_14, 19760076.
36. Nyambayar D, Iwabuchi K, Hedlund E, Murakawa S, Shirai K, Iwabuchi C, Kon Y, Miyazaki Y, Yanagawa Y, Onoe K. Characterization of NKT-cell hybridomas expressing invariant T-cell antigen receptors. J Clin Exp Hematop 2007, 47:1-8. 10.3960/jslrt.47.1, 17510531.
37. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007, 96:41-101.
38. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005, 23:877-900. 10.1146/annurev.immunol.23.021704.115742, 15771592.
39. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13:139-45. 10.1038/nm1551, 17290272.
40. Mills KH. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008, 38:2636-49. 10.1002/eji.200838535, 18958872.
41. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-64.
42. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998, 160:1212-8.
43. Shevach EM. Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med 2001, 193:F41-6. 10.1084/jem.193.11.F41, 2193387, 11390442.
44. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998, 10:371-8. 10.1093/intimm/10.4.371, 9620592.
45. Glimcher LH, Townsend MJ, Sullivan BM, Lord GM. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol 2004, 4:900-11. 10.1038/nri1490, 15516969.
46. Pearce EL, Mullen AC, Martins GA, Krawczyk CM, Hutchins AS, Zediak VP, Banica M, DiCioccio CB, Gross DA, Mao CA, et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 2003, 302:1041-3. 10.1126/science.1090148, 14605368.
47. Kassiotis G, Gray D, Kiafard Z, Zwirner J, Stockinger B. Functional specialization of memory Th cells revealed by expression of integrin CD49b. J Immunol 2006, 177:968-75.